Positive FDA Feedback on NDA Submission Process for TLX591-CDx (kit for the preparation of 68Ga-PSMA-11)
Telix Pharmaceuticals announces that it has received positive feedback from the FDA regarding its submission of an NDA for…
Read moreNews & Views
Telix Pharmaceuticals Releases Annual Report Year Ending 2019
Telix Pharmaceuticals Limited Releases Annual Report Year Ending…
Read more
European Leadership Changes and Appointment of VP Sales and Marketing, EMEA
News,
Telix Pharmaceuticals Limited announces that Ms Odile Jaume will be stepping down from her position of Telix EU…
Read more
Telix Supports Molecular Imaging Summer Program at MSKCC
Telix Pharmaceuticals Ltd is pleased to announce our support of the Molecular Imaging Summer Program at…
Read more
Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging
Telix Pharmaceuticals Limited is pleased to announce that the FDA has approved the ZIRCON study for American…
Read more
Robyn Jackson, MBA, CNMT Joins Telix Pharmaceuticals US
News,
With over 15 years of hands-on experience in Diagnostic Imaging and Sales, Robyn will be solidifying our presence in the Western US. Robyn has an extensive background in Diagnostic Imaging…
Read more
Anthony Zinno, MBA Joins Telix Pharmaceuticals US
News,
With more than 26 years of operations experience in the healthcare and life sciences field, Tony will be leading the sales organization as Vice President of Commercial Operations. Tony’s success…
Read more
NDA Clinical Briefing Package Submitted to the US FDA
Telix Pharmaceuticals announces that it has submitted a complete clinical briefing package to the US FDA for its first product…
Read more
ZIRCON Phase 3 IND Submitted to the US FDA
Telix Pharmaceuticals Limited announces that it has submitted a Phase 3 IND application to the FDA for…
Read more
TLX101 for Brain Cancer IPAX-1 Study Update
Telix Pharmaceuticals has released an update on the progress of its TLX101 product in the treatment of glioblastoma…
Read more